Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics-Reference-Cited by-同舟云学术

Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics

Published:2021-03-29 Issue:5 Volume:20 Page:2953-2963
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Chen Chao-Jung¹²,Chou Che-Yi³⁴⁵,Shu Kuo-Hsiung⁶,Chen Hung-Chun⁷,Wang Ming-Cheng⁸,Chang Chia-Chu⁹,Hsu Bang-Gee¹⁰,Wu Mai-Szu¹¹,Yang Yuan-Lung¹²,Liao Wen-Ling¹¹³,Yang Chieh¹⁴,Hsiao Yu-Tien¹⁴,Huang Chiu-Ching¹⁴

Affiliation:

1. Graduate Institute of Integrated Medicine, China Medical University, Taichung 404333, Taiwan

2. Proteomics Core Laboratory, Department of Medical Research, China Medical University Hospital, Taichung 404332, Taiwan

3. Department of Internal Medicine, Asia University Hospital, Taichung 41354, Taiwan

4. Department of Post-baccalaureate Veterinary Medicine, Asia University, Taichung, Taiwan

5. Division of Nephrology, China Medical University Hospital, Taichung 404332, Taiwan

6. Division of Nephrology, Lin Shin Hospital, Taichung 40867, Taiwan

7. Division of Nephrology, Kaohsiung Medical University and Hospitals, Kaohsiung 80708, Taiwan

8. Division of Nephrology, Cheng Kung University Hospital, Tainan 70403, Taiwan

9. Department of Internal Medicine, Kuang Tien General Hospital, Taichung 43303, Taiwan

10. Division of Nephrology, Buddhist Tzu Chi General Hospital, Hualien 43303, Taiwan

11. Division of Nephrology, Taipei Medical University and Hospitals, Taipei 110, Taiwan

12. Division of Urology, St. Mary’s Hospital, Yilan 26546, Taiwan

13. Center for Personalized Medicine, China Medical University Hospital, Taichung 404332, Taiwan

14. Division of Nephrology and the Kidney Institute, Department of Internal Medicine, China Medical University and Hospitals, Taichung 404332, Taiwan

Funder

Academia Sinica

Ministry of Science and Technology, Taiwan

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.1c00164

Reference53 articles.

1. The present and future burden of urinary bladder cancer in the world

2. Combinational treatment of all‐trans retinoic acid (ATRA) and bisdemethoxycurcumin (BDMC)‐induced apoptosis in liver cancer Hep3B cells

3. MULTIVARIATE ANALYSIS OF CLINICAL PARAMETERS OF SYNCHRONOUS PRIMARY SUPERFICIAL BLADDER CANCER AND UPPER URINARY TRACT TUMOR

4. Differences Between Local and Review Urinary Cytology in Diagnosis of Bladder Cancer. An Interobserver Multicenter Analysis

5. COST-EFFECTIVENESS OF A MODIFIED CARE PROTOCOL SUBSTITUTING BLADDER TUMOR MARKERS FOR CYSTOSCOPY FOR THE FOLLOWUP OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A DECISION ANALYTICAL APPROACH

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of GARS in bladder cancer and its role in the tumor microenvironment;Translational Cancer Research;2024-06

2. Comprehensive Urinary Proteome Profiling Analysis Identifies Diagnosis and Relapse Surveillance Biomarkers for Bladder Cancer;Journal of Proteome Research;2024-05-24

3. Instrumentation at the Leading Edge of Proteomics;Analytical Chemistry;2024-05-13

4. Recent progress in mass spectrometry-based urinary proteomics;Clinical Proteomics;2024-02-22

5. Exploration of potential biomarkers for early bladder cancer based on urine proteomics;Frontiers in Oncology;2024-02-12